pharmacie et médicaments – Développement de l'usage des médicaments biosimilaires

This written question concerns the development and use of biosimilar medicines in France. It seeks to understand the current situation and potential strategies to encourage their wider adoption. The question aims to gather information on how biosimilar medicines can improve patient access to treatments and potentially reduce healthcare costs, affecting patients and the pharmaceutical sector.